Search filters

List of works by Ricardo C Ribas

AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo.

scientific article

Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer.

scientific article

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

scientific article

Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer

scientific article

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance

scientific article published on 30 November 2017

ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1

scientific article

Effect of zona pellucida removal on DNA methylation in early mouse embryos

scientific article published on 12 October 2005

Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo

scientific article published on October 17, 2012

Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers.

scientific article

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer

scientific article published on 11 March 2015

Members of the TEAD family of transcription factors regulate the expression of Myf5 in ventral somitic compartments

scientific article published on 17 April 2011

Modifications to improve the efficiency of zona-free mouse nuclear transfer.

scientific article published in January 2006

Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation

scientific article

miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors

scientific article published on 21 January 2016